Mitsubishi Tanabe Pharma Corp. Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Mitsubishi Tanabe Pharma Corp.

Mitsubishi Tanabe Pharma Corp.

Mitsubishi Tanabe Pharma Corp. ADR
Stock Exchange	Other OTC
EPS	$0.6
Market Cap	$6.48 B
Shares Outstanding	561.42 M
Public Float	-

Mitsubishi Tanabe Pharma Corp.
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	561.42 M
Public Float	-

Mitsubishi Tanabe Pharma Corp.
Stock Exchange	Tokyo Stock Exchange
EPS	JPY66.64
Market Cap	JPY702.66 B
Shares Outstanding	561.42 M
Public Float	220.14 M

Profile

Address	3-2-10 Dosho-machi Osaka Osaka 541 Japan
Employees	-
Website	http://www.mt-pharma.co.jp
Updated	07/08/2019
Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company operates through Pharmaceuticals segment.

Financials

Masayuki Mitsuka

President, CEO & Representative Director

Eizou Tabaru

Director, General Manager-Finance & Accounting